-+ 0.00%
-+ 0.00%
-+ 0.00%

Aptamer, Pharmahungary to Research Therapeutics Delivery to Heart, Skeletal Muscle

MT Newswires·10/26/2026 05:39:10
Listen to the news
05:39 AM EDT, 10/26/2026 (MT Newswires) -- Aptamer Group (APTA.L) agreed to collaborate with biotechnology company Pharmahungary Group for research into the targeted delivery of oligonucleotide therapeutics to the heart and skeletal muscle. The London-listed British synthetic binder developer said Monday it will explore a potential pharmaceutical partnership with Pharmahungary as part of the cost-sharing research collaboration. Aptamer is aiming to develop two Optimer delivery vehicles for the heart and skeletal muscle and manufacture lead conjugates using its partner's therapeutic microRNA through the collaboration.